Informazioni
Dr Alzouebi is a Consultant Clinical Oncologist at Weston Park Hospital, specialising in the treatment of cancers of the urinary tract, particularly prostate, kidney, and bladder cancer. She is an expert in using the most advanced and up-to-date treatment modalities, including systemic anti-cancer chemotherapy, immunotherapy, and radiotherapy. Dr Alzouebi is actively involved in clinical trials and research, and is the local principal investigator on several national clinical trials.
She completed her general medical training in the Yorkshire Deanery, achieving MRCP and DTMH qualifications, and completed the Clinical Oncology Training Programme at Weston Park Hospital in Sheffield. She obtained a Distinction in a Master’s Degree in Oncology from the University of Nottingham and her dissertation research was published in a peer-reviewed journal. Dr Alzouebi holds a substantive NHS post as a Consultant Clinical Oncologist at Sheffield Teaching Hospital NHS Foundation Trust.
Her treatments include Systemic Drug Therapy/Chemotherapy (Novel Targeted Anticancer Drug Treatment, Systemic Chemotherapy, Immunotherapy, Monoclonal Antibodies, Endocrine Therapy, Radium-223, and Tyrosine Kinase therapy) and Radiotherapy (Intensity Modulated Radiotherapy, Image Guided Radiotherapy, Adaptive Radiotherapy, Stereotactic Ablative Radiotherapy, and SABR). Her areas of interest include Advanced Radiotherapy Techniques for Prostate and Bladder Cancer, Prostate SABR, and Chemotherapy in Prostate, Kidney, and Bladder Cancer. Dr Alzouebi also works in partnership with Genesiscare to offer SpaceOAR for prostate radiotherapy.
She completed her general medical training in the Yorkshire Deanery, achieving MRCP and DTMH qualifications, and completed the Clinical Oncology Training Programme at Weston Park Hospital in Sheffield. She obtained a Distinction in a Master’s Degree in Oncology from the University of Nottingham and her dissertation research was published in a peer-reviewed journal. Dr Alzouebi holds a substantive NHS post as a Consultant Clinical Oncologist at Sheffield Teaching Hospital NHS Foundation Trust.
Her treatments include Systemic Drug Therapy/Chemotherapy (Novel Targeted Anticancer Drug Treatment, Systemic Chemotherapy, Immunotherapy, Monoclonal Antibodies, Endocrine Therapy, Radium-223, and Tyrosine Kinase therapy) and Radiotherapy (Intensity Modulated Radiotherapy, Image Guided Radiotherapy, Adaptive Radiotherapy, Stereotactic Ablative Radiotherapy, and SABR). Her areas of interest include Advanced Radiotherapy Techniques for Prostate and Bladder Cancer, Prostate SABR, and Chemotherapy in Prostate, Kidney, and Bladder Cancer. Dr Alzouebi also works in partnership with Genesiscare to offer SpaceOAR for prostate radiotherapy.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Mymoona Alzouebi
Istruzione e formazione
-
2005–2011 MD · Medicine and Surgery
-
2011–2015 Residency · Oncologia
Carriera e incarichi
-
2015-09–2016-08 Junior consultant
Licenze e assicurazione
Licenze mediche
GB — Organización Médica Colegial de España (OMC)
Certificazioni di specializzazione
European Board of Oncologia
Assicurazione responsabilità professionale:
AXA Healthcare Liability · 1,000,000 EUR copertura · No claims on file
Procedure eseguite
| Procedura | Codice | Conteggio totale |
|---|---|---|
| GP consultation | 99213 | 1,819 |
| Annual physical exam | 99395 | 1,237 |
| Vaccination administration | 90471 | 1,053 |
| Minor procedure (skin) | 17110 | 586 |
Servizi e prezzi
| Servizio | Durata | Modalità | Prezzo |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 90 min | in_clinic | 360.00 EUR |
| Minor procedure (skin) | 60 min | in_clinic | 270.00 EUR |
Studio, team e in pratica
Video
Ricerca e pubblicazioni
indice h: 15 · i10: 15
-
Long-term follow-up of Oncologia across GB
DOI: 10.9711/euroclin.2026.0 · PMID: 36234510 · citato da 187
-
Validation of clinical scoring in Oncologia
DOI: 10.9456/euroclin.2025.1 · PMID: 31706029 · citato da 81
-
Long-term follow-up of Oncologia across GB
DOI: 10.9648/euroclin.2024.2 · PMID: 36028681 · citato da 39
-
Validation of clinical scoring in Oncologia
DOI: 10.3301/euroclin.2023.3 · PMID: 37363220 · citato da 37
Conferenze su invito
- Practical updates in Oncologia European Annual Congress (Oncologia) · Vienna · 2024 · invited
- Single-centre experience in Oncologia National Society Meeting · Sheffield · 2023 · oral abstract
Premi e affiliazioni
Premi
- 🏆 Top-rated Oncologia — Sheffield · EuroClinics Patient Choice · 2025 · regional
Iscrizioni a società
- WONCA Europe — Family Doctors — Member · Dal 2016
- national college of family doctors — Member · Dal 2016
- European Union of Medical Specialists (UEMS) — Member · Dal 2016
Articoli di questo medico
- Patient education Patient guide to Oncologia
- Awareness When should you see a oncologia?
Per pazienti internazionali
- Coordinatore
- Patient liaison · dr.mymoona.alzouebi@euroclinics.example
Posizione
1 tagRecensioni dei pazienti
Condividi la tua esperienza — aiuta altri pazienti a trovare il medico giusto. Scrivi una recensione →
Recensioni recenti
-
★★★★★ ✓ Verificato Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verificato Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verificato Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.